Equity Field Notes from temporal sources

[DanWebzster]

KDMN ( scientific backgrounder)

KDMN focus is on Roh Kinases. Roh Kinases are differentiated in their ability to regulate cytoskeletons.

Roh Kinases are referred to colloquially as either ROCK-1 and ROCK-2

ROCK-1 are active in cytoskeleton destruction throughout the body, but especially in liver, spleen and kidney.

ROCK-2 are active in brain and muscle development and stabilization.

KDO25 is KDMN's in-licensed ROCK Inhibitor that KDMN has made more selective to ROCK-2 inhibition. Theoretically, these changes have made this ROCK Inhibitor therapeutic against fibrotic diseases.